Momenta Pharmaceuticals, Inc. (MNTA) to Present at the Canaccord Genuity 32nd Annual Growth Conference
8/9/2012 10:15:35 AM
CAMBRIDGE, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Canaccord Genuity 32nd Annual Growth Conference will be webcast on Wednesday, August 15 at 9:00 a.m. ET.
comments powered by